The Wilmington, N.C.-based medical device company TranS1 has reached a $6 million agreement with the US Department of Justice to settle a federal investigation. TranS1, which develops and designs devices for degenerative lower lumber spine conditions, admits no wrongdoing as part of the settlement, according to the report.
The settlement should be finalized within the next few months.
More Articles on Devices:
Life Spine Releases Lateral Retractor, Spacer Devices
NUI Galway Plans Release of OsteoAnchor Joint Technology
Drug-Device Combination Market to Reach $30.5B by 2017
The settlement should be finalized within the next few months.
More Articles on Devices:
Life Spine Releases Lateral Retractor, Spacer Devices
NUI Galway Plans Release of OsteoAnchor Joint Technology
Drug-Device Combination Market to Reach $30.5B by 2017